Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CERTOLIZUMAB PEGOL Cause Visual impairment? 945 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 945 reports of Visual impairment have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 1.0% of all adverse event reports for CERTOLIZUMAB PEGOL.

945
Reports of Visual impairment with CERTOLIZUMAB PEGOL
1.0%
of all CERTOLIZUMAB PEGOL reports
395
Deaths
358
Hospitalizations

How Dangerous Is Visual impairment From CERTOLIZUMAB PEGOL?

Of the 945 reports, 395 (41.8%) resulted in death, 358 (37.9%) required hospitalization, and 277 (29.3%) were considered life-threatening.

Is Visual impairment Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 945 reports have been filed with the FAERS database.

What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?

Drug ineffective (23,838) Rheumatoid arthritis (17,782) Pain (13,929) Fatigue (11,438) Off label use (10,281) Rash (9,663) Alopecia (9,111) Maternal exposure during pregnancy (9,013) Arthralgia (8,993) Abdominal discomfort (8,615)

What Other Drugs Cause Visual impairment?

INSULIN GLARGINE (5,793) INSULIN LISPRO (4,654) ADALIMUMAB (3,770) DUPILUMAB (3,089) ETANERCEPT (2,489) FINGOLIMOD (2,147) AFLIBERCEPT (1,836) PREGABALIN (1,714) METHOTREXATE (1,588) TOFACITINIB (1,544)

Which CERTOLIZUMAB PEGOL Alternatives Have Lower Visual impairment Risk?

CERTOLIZUMAB PEGOL vs CERTOPARIN CERTOLIZUMAB PEGOL vs CETIRIZINE CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE CERTOLIZUMAB PEGOL vs CETRIMIDE CERTOLIZUMAB PEGOL vs CETRORELIX

Related Pages

CERTOLIZUMAB PEGOL Full Profile All Visual impairment Reports All Drugs Causing Visual impairment CERTOLIZUMAB PEGOL Demographics